Invasive Early Breast Cancer

Also known as: Invasive, early Breast Cancer

Drug	Drug Name	Drug Description
DB01217	Anastrozole	A competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of hormone receptor-positive breast cancer in postmenopausal women.

Drug	Drug Name	Target	Type
DB01217	Anastrozole	Cytochrome P450 19A1	target
DB01217	Anastrozole	P-glycoprotein 1	transporter
DB01217	Anastrozole	Cytochrome P450 3A4	enzyme
DB01217	Anastrozole	Cytochrome P450 3A5	enzyme
DB01217	Anastrozole	Cytochrome P450 2C8	enzyme
DB01217	Anastrozole	UDP-glucuronosyltransferase 1-4	enzyme
DB01217	Anastrozole	UDP-glucuronosyltransferase 1-3	enzyme
DB01217	Anastrozole	UDP-glucuronosyltransferase 2B7	enzyme
DB01217	Anastrozole	Cytochrome P450 1A2	enzyme
DB01217	Anastrozole	Cytochrome P450 2C9	enzyme

Drug	Drug Name	Phase	Status	Count
DB00990	Exemestane	Not Available	Terminated	1